ALS (motor neurone disease) trials in South Korea

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

  Where

  Seoul

  Age

  18 years and over

  People

  54 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT06351592 · EU 2023-510344-20-00
• Phase 1Taking people
  A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

  Where

  Seoul

  Age

  19 years and over

  People

  64

  Run by

  1ST Biotherapeutics, Inc.

  See details and how to joinNCT05995782